title: Life-Threatening Cutaneous Bleeding in Childhood Klippel-Trenaunay Syndrome Treated With Oral Sirolimus.
authors.affiliation: Department of Dermatology, Saint-Eloi Hospital, University Hospital of Montpellier, Montpellier, France2University of Montpellier, Montpellier, France3INSERM U1058, Montpellier, France.
authors.forename: Didier
authors.initials: D
authors.lastname: Bessis
authors.affiliation: Department of Radiology, Lapeyronie Hospital, University Hospital of Montpellier, Montpellier, France.
authors.forename: Hélène
authors.initials: H
authors.lastname: Vernhet
authors.affiliation: Department of Pediatric Infantile Surgery, Lapeyronie Hospital, University Hospital of Montpellier, Montpellier, France.
authors.forename: Michèle
authors.initials: M
authors.lastname: Bigorre
authors.affiliation: Department of Internal Medicine, Saint-Eloi Hospital, University Hospital of Montpellier, Montpellier, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Quéré
authors.affiliation: Department of Pediatric Oncology and Hematology, Arnaud de Villeneuve Hospital, University Hospital of Montpellier, Montpellier, France.
authors.forename: Jochen
authors.initials: J
authors.lastname: Rössler
mesh_terms: D000284:Administration, Oral; D016638:Critical Illness; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007223:Infant; D007715:Klippel-Trenaunay-Weber Syndrome / Q000150:complications* / Q000175:diagnosis; D008297:Male; D020123:Sirolimus / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D020123:Sirolimus